Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print McGill researchers overcome chemotherapy resistance in the lab

McGill researchers overcome chemotherapy resistance in the lab

June 30, 2008

Re-purposed Malaysian folk medication reduces resistance to cancer treatments

Researchers from McGill University's Faculty of Medicine have discovered a compound that reduces resistance to chemotherapy agents used to treat cancer. Their results were published in the June issue of The Journal of Clinical Investigation (JCI).




Dr. Jerry Pelletier, PhD candidate Marie-Eve Bordeleau, and post-doctoral fellow Francis Robert, of the Department of Biochemistry and the McGill Cancer Centre - along with colleagues from Boston University, the Sloan-Kettering Cancer Center, the University of Vienna and the Howard Hughes Medical Institute - conducted an extensive study on a class of natural products known as cyclopenta benzofuran flavaglines (CBF).

Working with mice genetically modified to mimic human leukemias, they discovered that one particular CBF compound, silvestrol, can effectively re-sensitize tumors to chemotherapy, making them susceptible to the killing effects of anticancer drugs.

"One of the major problems with cancer therapy is that the tumours either fail to respond or stop responding over time to various chemotherapy drugs," Pelletier said. "One reasonable explanation for why this happens is the normal process of protein synthesis in the cell is usurped, principally because cancer cells grow faster and have higher metabolic needs. The normal checks and balances are no longer present."

Pelletier's lab at the Department of Biochemistry and McGill Cancer Centre focuses on high-throughput assays of various compounds to determine their anti-cancer effectiveness. One that showed promise was silvestrol, a natural compound derived from Aglaia silvestris, a large genus of trees and shrubs found in Malaysia, South China and some Pacific islands. It has been used in Malaysian folk medicine for generations, but never as a cancer therapy.

"We made a conscious decision early on in our research to also screen for natural products," Pelletier says. "Silvestrol is not a synthetic compound you can buy from commercial suppliers."

In the lab, Pelletier explained, silvestrol therapy re-sensitized leukemia cells which had already demonstrated resistance to the chemotherapy agent doxorubicin.

"Essentially, we have turned off the cancer cell's survival signals, which is associated with resistance," he said.

However, he cautioned, though synthetic silvestrol is now starting to become available, trials in humans and possible treatments are still many years away.


McGill University



Related Chemotherapy Current Events and Chemotherapy News Articles Chemotherapy Current Events and Chemotherapy News RSS Chemotherapy Current Events and Chemotherapy News RSS
Hodgkin lymphoma -- new characteristics discovered
Researchers are still discovering new characteristics of Hodgkin lymphoma, a common form of cancer of the lymphatic system. The malignant cells are derived from white blood cells (B cells), but have lost a considerable part of the B cell-specific gene expression pattern.

Bisphenol A linked to chemotherapy resistance
Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists.

Pediatric study finds alternatives for radiation of low-grade brain tumors
A multi-institutional study led by researchers at The University of Texas M. D. Anderson Cancer Center has found that using chemotherapy alone and delaying or avoiding cranial radiation altogether can be effective in treating pediatric patients with unresectable or progressive low-grade glioma.

Mayo researchers explore issues related to multiple myeloma treatment
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients.

News from Cancer: Disparities in head and neck cancer patients
A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer.

Nanodiamond drug device could transform cancer treatment
A Northwestern University research team has developed a promising nanomaterial-based biomedical device that could be used to deliver chemotherapy drugs locally to sites where cancerous tumors have been surgically removed.

Children's National researchers develop novel anti-tumor vaccine
A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice.

Surgical treatment provides new option for some colorectal cancer patients
Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients.

Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
In pre-clinical studies, vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say researchers at Memorial Sloan-Kettering Cancer Center.

Hepatitis B exposure may increase risk for pancreatic cancer
In a first-of-its-kind finding, researchers at The University of Texas M. D. Anderson Cancer Center have discovered that exposure to the hepatitis B virus (HBV) may increase the risk of pancreatic cancer.
More Chemotherapy Current Events and Chemotherapy News Articles


The Chemotherapy & Radiation Therapy Survival Guide (Chemotherapy and Radiation Therapy Survivor's Guide)
by Judith McKay, Nancee Hirano



Physician's Cancer Chemotherapy Drug Manual 2008 (Jones and Bartlett Series in Oncology)
by Edward Chu, Vincent T. DeVita Jr.

Completely revised and updated for 2008, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalogue of over 100 drugs-both on- and off-label-commonly used in cancer treatment. A section on Common Chemotherapy Regimens provides a quick reference to management of specific cancers, arranged...



Chemotherapy and Radiation For Dummies
by Alan P. Lyss, Humberto Fagundes, Patricia Corrigan

An informative, compassionate guide for cancer patients and their loved ones Each year, more than 1 million people get treated for cancer, and most of these will undergo chemotherapy, radiation therapy, or both. This reassuring, optimistic guide helps people get a handle on treatment options and explains in plain English how chemotherapy and radiation therapy really work. It offers detailed...



Chemotherapy Heals Cancer and the World is Flat
by Lothar Hirneise

In the future there will be two groups of cancer patients. Those who have read this book - and those who are uninformed. For many years Lothar Hirneise has been traveling throughout the world looking for the most successful cancer therapies, and he has been explaining to people that there is much more available than just chemotherapy and irradiation. Recognized internationally as Europe's leading...



Questioning Chemotherapy
by Ralph W. Moss

A revealing critique of chemotherapy, this book looks objectively at chemo's successes and...



Coping With Chemotherapy and Radiation Therapy
by Daniel Cukier

New advances in treatment offer cancer patients more options than ever before. Coping with Chemotherapy and Radiation is an accessible, accurate guide to the latest developments in radiation therapy and chemotherapy. You will find important information on how chemotherapy and radiation treatments work; what to expect from treatments, how to alleviate common side effects, and...



Chemotherapy and Biotherapy Guidelines and Recommendations for Practice (second edition)

Order your copy of the newly revised and updated second edition of your #1 resource for chemotherapy administration! With more than 46,000 copies sold since 2001, you and thousands of your colleagues in oncology nursing have studied and consulted the information found in the first edition. The new second edition is based on current evidence and has been revised and updated to reflect the...



Coping with Chemotherapy: Compassionate Advice and Authoritative Information from a Chemotherapy Survivor
by Nancy Bruning

After undergoing chemotherapy herself, author Nancy Bruning decided to write a candid and authoritative book to fill the void of information available for patients facing this procedure. In this completely revised, updated, and thoroughly researched edition, she details every step of the process, providing information even doctors neglect to tell their patients, including possible sexual and...



The Cancer Chemotherapy Handbook (6th Edition)
by David S. Fischer, Henry J. Durivage, M. Tish Knobf, Nancy Beaulieu

Here's a comprehensive, yet compact and practical guide to the care and chemotherapeutic treatment of cancer patients. It encompasses all major chemotherapeutic agents and combinations, investigational and newly approved drugs, and describes their mechanisms of action, indications, metabolism, dose, administration, toxicity, and drug interactions and incompatibilities. The 6th Edition includes...



The Chemotherapy Source Book

The Chemotherapy Source Book, Fourth Edition pulls together all the current information on the chemotherapeutic management of cancer patients, including choice of chemotherapeutic agents, use of combinations, and toxicity of individual drugs. Organized by disease site, the book brings together pharmacologic and patient management information in one source that clinicians can consult for any...

© 2008 BrightSurf.com